Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Dose-Finding Study of Lu AA24530 in Major Depressive Disorder.

Trial Profile

Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Dose-Finding Study of Lu AA24530 in Major Depressive Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2016

At a glance

  • Drugs Tedatioxetine (Primary) ; Duloxetine
  • Indications Depression; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.
    • 02 Jul 2009 Positive headline results released by Lundbeck.
    • 19 Jun 2009 Additional locations identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top